These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


865 related items for PubMed ID: 17386356

  • 1. Urinary free cortisol is not a biochemical marker of hypertension.
    Krall P, Carvajal C, Ortiz E, Muñoz C, Garrido JL, Mosso L, Fardella C.
    Am J Hypertens; 2007 Apr; 20(4):459-65. PubMed ID: 17386356
    [Abstract] [Full Text] [Related]

  • 2. [Possible pathogenetic role of 11 beta-hydroxysteroid dehydrogenase type 1 (11betaHSD1) gene polymorphisms in arterial hypertension].
    Morales MA, Carvajal CA, Ortiz E, Mosso LM, Artigas RA, Owen GI, Fardella CE.
    Rev Med Chil; 2008 Jun; 136(6):701-10. PubMed ID: 18769825
    [Abstract] [Full Text] [Related]

  • 3. [Free urinary cortisol is elevated in patients with low-renin essential hypertension].
    Krall P, Mosso L, Carvajal C, Rojas A, Fardella C.
    Rev Med Chil; 2004 Sep; 132(9):1053-9. PubMed ID: 15543761
    [Abstract] [Full Text] [Related]

  • 4. [11 beta-hydroxysteroid dehydrogenase type 2 activity in Chilean patients with hypertension].
    Mosso L, Carvajal C, Campino C, Rojas A, González A, Barraza A, Montero J, Fardella C.
    Rev Med Chil; 2002 Nov; 130(11):1201-8. PubMed ID: 12587501
    [Abstract] [Full Text] [Related]

  • 5. A polymorphic GT short tandem repeat affecting beta-ENaC mRNA expression is associated with low renin essential hypertension.
    González AA, Carvajal CA, Riquelme E, Krall PM, Munoz CR, Mosso LM, Kalergis AM, Fardella CE.
    Am J Hypertens; 2007 Jul; 20(7):800-6. PubMed ID: 17586416
    [Abstract] [Full Text] [Related]

  • 6. Serum aldosterone and protein-binding variables in Yanomama Indians: a no-salt culture as compared to partially acculturated Guaymi Indians.
    Nowaczynski W, Oliver WJ, Neel JV.
    Clin Physiol Biochem; 1985 Jul; 3(6):289-306. PubMed ID: 3907928
    [Abstract] [Full Text] [Related]

  • 7. Age-related changes in 11β-hydroxysteroid dehydrogenase type 2 activity in normotensive subjects.
    Campino C, Martinez-Aguayo A, Baudrand R, Carvajal CA, Aglony M, Garcia H, Padilla O, Kalergis AM, Fardella CE.
    Am J Hypertens; 2013 Apr; 26(4):481-7. PubMed ID: 23443726
    [Abstract] [Full Text] [Related]

  • 8. Plasma cortisol and corticosteroid-binding globulin in essential hypertension.
    Nowaczynski W, Wilkins GE, Murakami T, Mavoungou D, Levin J.
    Clin Physiol Biochem; 1988 Apr; 6(2):82-94. PubMed ID: 2841062
    [Abstract] [Full Text] [Related]

  • 9. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S, Bernheim J, Podjarny E.
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [Abstract] [Full Text] [Related]

  • 10. 11beta-Hydroxysteroid dehydrogenase type 2 activity is associated with left ventricular mass in essential hypertension.
    Glorioso N, Filigheddu F, Parpaglia PP, Soro A, Troffa C, Argiolas G, Mulatero P.
    Eur Heart J; 2005 Mar; 26(5):498-504. PubMed ID: 15618035
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Glucocorticoid Metabolism in Hypertensive Disorders of Pregnancy: Analysis of Plasma and Urinary Cortisol and Cortisone.
    Kosicka K, Siemiątkowska A, Krzyścin M, Bręborowicz GH, Resztak M, Majchrzak-Celińska A, Chuchracki M, Główka FK.
    PLoS One; 2015 Mar; 10(12):e0144343. PubMed ID: 26637176
    [Abstract] [Full Text] [Related]

  • 13. Urinary free cortisone, but not cortisol, is associated with urine volume in severe obesity.
    Müssig K, Remer T, Fritsche A, Häring HU, Maser-Gluth C.
    Steroids; 2009 Sep; 74(9):742-5. PubMed ID: 19541001
    [Abstract] [Full Text] [Related]

  • 14. The role of biochemical tests and clinical symptoms in differential diagnosis of primary aldosteronism.
    Prejbisz A, Postuła M, Cybulska I, Dobrucki T, Kabat M, Peczkowska M, Janas J, Janaszek-Sitkowska H, Makowiecka-Cieśla M, Januszkiewicz A.
    Kardiol Pol; 2003 Jan; 58(1):17-26. PubMed ID: 14502298
    [Abstract] [Full Text] [Related]

  • 15. [Differences of blood plasma renin activity, angiotensin II and aldosterone levels in essential or secondary hypertension].
    Song AL, Zeng ZP, Tong AL, Lu L, Chen S, Li M, Fu CL, Wang YH, Sun ML.
    Zhonghua Nei Ke Za Zhi; 2012 Apr; 51(4):294-8. PubMed ID: 22781950
    [Abstract] [Full Text] [Related]

  • 16. Primary hyperaldosteronism in essential hypertensives: prevalence, biochemical profile, and molecular biology.
    Fardella CE, Mosso L, Gómez-Sánchez C, Cortés P, Soto J, Gómez L, Pinto M, Huete A, Oestreicher E, Foradori A, Montero J.
    J Clin Endocrinol Metab; 2000 May; 85(5):1863-7. PubMed ID: 10843166
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Hormonal profile and participation of nitric oxide in salt-sensitive and salt-resistant essential arterial hypertension].
    Gómez-Fernández P, Moreno VG, Cornejo M, Vargas JC, García-Barroso C, Velasco G, Almaraz M.
    Nefrologia; 2000 May; 20(5):415-23. PubMed ID: 11100662
    [Abstract] [Full Text] [Related]

  • 19. The renin-angiotensin system in malignant hypertension revisited: plasma renin activity, microangiopathic hemolysis, and renal failure in malignant hypertension.
    van den Born BJ, Koopmans RP, van Montfrans GA.
    Am J Hypertens; 2007 Aug; 20(8):900-6. PubMed ID: 17679041
    [Abstract] [Full Text] [Related]

  • 20. [The captopril test--an aid in the detection of scarring nephropathy as a cause of arterial hypertension in children].
    Peco-Antić A, Nastić-Mirić D, Babić D, Kostić M.
    Srp Arh Celok Lek; 1999 Aug; 127(9-10):305-11. PubMed ID: 10649899
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 44.